The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0333
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma

Oncotarget
Oncology
2015English

Inhibition of Autophagy Potentiates the Efficacy of Gli Inhibitor GANT-61 in MYCN-amplified Neuroblastoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

The Long Non-Coding RNA MYCNOS-01 Regulates MYCN Protein Levels and Affects Growth of MYCN-amplified Rhabdomyosarcoma and Neuroblastoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Epigenetic Regulation of the Neuroblastoma Genes, Arid3b and Mycn

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

ABCC4/MRP4: A MYCN-regulated Transporter and Potential Therapeutic Target in Neuroblastoma

Frontiers in Oncology
Cancer ResearchOncology
2012English

Burkholderia Lethal Factor 1, a Novel Anti-Cancer Toxin, Demonstrates Selective Cytotoxicity in MYCN-Amplified Neuroblastoma Cells

Toxins
MutagenesisToxicologyHealth
2018English

The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma

Cancer Cell
Cancer ResearchOncologyCell Biology
2012English

P53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy